Drawing for AMERISOURCEBERGEN

USPTO serial 86522898

AMERISOURCEBERGEN

Reviewed by CopyMark Law Group

Reg. 5291426Status 702Renewal
Filing date
Status date
Registration date
Sep 19, 2017
Examiner
JACKSON, STEVEN W
Law office
TMEG LAW OFFICE 107

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with AMERISOURCEBERGEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,046*

Plus Government fees of $2,600

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Patrick C. Stephenson

Patrick C. Stephenson Kutak Rock LLP1650 Farnam St.Omaha, NE 68102UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Distributorships in the field of specialty pharmaceutical products, namely, disease specific pharmaceuticals; mail order services featuring pharmaceutical [and biotechnological ] products; [cooperative advertising and marketing in the field of biotechnological products; business consultation in the field of development and commercialization of biotechnological products;] providing an online computer database featuring information about consumer product sales at retail locations, about wholesale product sales to outlets, and about inventory management of health-care products for use by commercial entities; providing an online computer database featuring information about wholesale product sales to outlets and about inventory management of pharmaceuticals for use by commercial entities; business consulting services in the field of pharmaceuticals and other healthcare technologies, namely, the application of analytical and statistical methodology to the study of healthcare products and their impact on the overall healthcare market, advertising and marketing services in the field of healthcare products and services, and services rendered to healthcare providers and pharmacies relating to containing drug acquisition costs and recovering allowable reimbursement; business administration services in the healthcare field for pharmaceutical, biotechnology and medical device suppliers, namely, business consulting services in the cost and payment management of health care; cost containment in the field of healthcare, namely, providing expedited review, processing and follow-up of prior authorization requests initiated by physicians' offices and pharmacies, providing group purchasing of pharmaceuticals and chemotherapeutics for community-based providers, namely, oncologists and oncology practices, business consultation services in the field of reimbursement for medical services rendered; conducting market research surveys in the field of healthcare costs and delivery; temporary staffing for pharmacies, namely, employment recruiting of pharmacy personnel, and interim business management and operation of pharmacy operational and clinical functions for others; [providing business support staff services to manufacturers of pharmaceuticals;] distributorships featuring specialty healthcare products in the nature of pharmaceuticals and chemotherapeutics supplied in accordance with specially developed protocols to health-care providers and their patients; [ preparing business reports to insurance agencies regarding drug therapy efficacy; retail pharmacy services featuring specialty pharmaceuticals and chemotherapeutics;] organization of business meetings and conventions for the purpose of disseminating information about the development, commercialization, and distribution of products and services in the field of healthcare; wholesale pharmaceutical and medical supply distributorship services, namely, distributorships in the field of prescription medication, non-prescription medication, vaccines, biologicals, injectables, pharmaceuticals and medical and surgical supplies, to hospitals, extended care facilities, clinics, doctor's offices, and nursing homes for the elderlyACTIVEJun 23, 2017
036Financial administration of reimbursement programs for healthcare providers and pharmacies relating to containing drug acquisition costs; financial consultancy in the field of insurance coverageACTIVEJun 23, 2017
042technology consultation and research in the pharmaceutical and healthcare fields, including the application of analytical and statistical methodology to the study of healthcare products and their impact on the overall healthcare market; developing business information solutions, namely, developing computer software for use in managing information in the field of healthcare patient assistance programs, patient reimbursement and insurance coverage; providing a website featuring non-downloadable procurement and inventory management software that enables users to requisition, track the location of, monitor use, and automatically create electronic purchase orders to suppliers with regard to medical, surgical and hospital products; customized computer system analysis services for others, for automated pharmaceutical dispensing systems and automated article dispensing systems used in pharmacies and similar premises; [consulting services in the field of design, selection, implementation and use of computer software systems for others;] computer software design for others for automated pharmaceutical dispensing systems and automated article dispensing systems used in pharmacies and similar premises; and technical support services, namely, troubleshooting in the nature of diagnosing problems with automated pharmaceutical dispensing systems and automated article dispensing systems used in pharmacies and similar premisesACTIVEJun 23, 2017
044Providing health information to the health industryACTIVEJun 23, 2017

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 19, 2026REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jun 26, 2023NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Jun 26, 2023C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Jun 23, 2023APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 28, 2022E815TEAS SECTION 8 & 15 RECEIVED—
Sep 19, 2022REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Dec 17, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 17, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 3, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 3, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 3, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 3, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 3, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Feb 20, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 20, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 19, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 17, 2017SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Aug 16, 2017CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jul 29, 2017SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jul 24, 2017AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 28, 2017IUAFUSE AMENDMENT FILED—
Jun 28, 2017EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Dec 23, 2016EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 21, 2016EX1GSOU EXTENSION 1 GRANTED—
Dec 21, 2016EXT1SOU EXTENSION 1 FILED—
Dec 21, 2016EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 28, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 28, 2016CHPBPOST PUBLICATION AMENDMENT - ENTERED—
May 24, 2016APETASSIGNED TO PETITION STAFF—
May 4, 2016EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
May 3, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
May 3, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 13, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 30, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 25, 2016TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 24, 2016CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 24, 2016ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Oct 28, 2015ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 21, 2015ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Oct 13, 2015GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Oct 13, 2015GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Oct 13, 2015CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 23, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 23, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 23, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 24, 2015GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2015GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 24, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 18, 2015DOCKASSIGNED TO EXAMINER—
Feb 13, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Feb 12, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 6, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance